raist@ I accept your arguing as well spoken and thought through.
And I do see the sense in much of what you saying.
You obviously know US conditions of 'how to du business' much better than me - so I consider your point about 'Using money for Lobbyisme' maybe the most important point (if Amarin did not do that at all) - even though it is 'corruption at its core for me' - if that's what is needed to 'move forward' - DO IT.
To your point about advertising to consumer right after R-I - as I understand these adds has to be FDA approved (DTS approval - sometime in may or june - was it ?)
Well I don't think we get any closer to agreement - but I thank you for your inputs. Getting a little viser regarding 'this maniac' investment of mine all the time.
And hope the best for myself' and your - 'I understand' major investment - 'on the line here' also. Can only get better from here :)
“I don't blame JT for not selling the company cheap”.
I guess we would need to know more particulars. $20 or $25 or $35 might have been too cheap to JT at the time but look at the stock price now. I have read many posters saying they would take $20, $15, and some $7 now.
News 
Market Data 
Discover 
